West PharmaceuticalWST $272.11 (19.71%), a company that sells a tiny rubber component of GLP-1 pens, is up more than 20% after it reported earnings that crushed Wall Street estimates thanks to soaring demand for the weight-loss drugs.
The company reported adjusted earnings per share of $1.84, compared to the $1.51 analysts polled by FactSet were expecting. It also reported $766.5 million in sales, more than the $726.1 million the Street was penciling in.
The company attributed the strong report to growth in its GLP-1 elastomers, which are small rubber components that go into the pens that deliver the blockbuster weight-loss drugs made by Novo NordiskNVO $70.74 (1.01%) and Eli LillyLLY $807.23 (1.04%). Those parts accounted for 8% of sales for the quarter, the company said.
https://sherwood.news/markets/west-pharmaceutical-rockets-on-surging-glp-1-demand/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.